FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Source: News Medical, https://www.news-medical.net/